Last reviewed · How we verify
NCT04185896: MADRE
Perinatal Mental Health Care in Switzerland
trial in Mental Disorder in 24 participants. Status unknown.
29 February 2020
Quick facts
| Lead sponsor | Bern University of Applied Sciences |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 24 |
| Start date | 10 July 2019 |
| Primary completion | 29 February 2020 |
| Estimated completion | 29 February 2020 |
| Sites | 1 location across Switzerland |
Conditions studied
- Mental Disorder — all drugs for Mental Disorder →
- Perinatal — all drugs for Perinatal →
- Depression — all drugs for Depression →
- Anxiety Disorders — all drugs for Anxiety Disorders →
Sponsor
Bern University of Applied Sciences
Who can join
18 and older, any sex, with Mental Disorder or Perinatal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This qualitative study with quantitative elements examines the health care provided to women who suffered from mental disorder during pregnancy and / or in the first year after birth (i.e. during the perinatal phase). Investigators will perform individual interviews with former PMD patients, and health and social care professionals to gain insights into current health care for PMD patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Perinatal mental health care from the user and provider perspective: protocol for a qualitative study in Switzerland.
Berger A, Schenk K, Ging A, Walther S, et al · · 2020 · cited 3× · PMID 32066475 · DOI 10.1186/s12978-020-0882-7
Verify or expand the search:
- PubMed search for NCT04185896
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mental Disorder
Currently open trials in the same condition.
- NCT07010614 — Brain Stimulation to the Hippocampus in Schizophrenia · NA · recruiting
- NCT06929533 — Pharmacogenomics-Supported Psychotropic Prescribing Trial · NA · recruiting
- NCT06813066 — Simulating Psychotherapeutic Sessions With Generative Artificial Intelligence · NA · active not recruiting
- NCT06376734 — Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness · Phase 2 · recruiting
- NCT06625437 — ACT for HIV-Positive Men · NA · recruiting
Other Bern University of Applied Sciences trials
Trials by the same sponsor.
- NCT07101978 — Hyperthermia in Patients With Chronic Primary Pain - Effects on Thermoregulation, Somatosensory System and Movement Evok · NA · not yet recruiting
- NCT07176845 — Exploring Multidimensional Trajectories in People With Low Back Pain · not yet recruiting
- NCT06104995 — Back Beliefs Among the General Population · NA · completed
- NCT07443098 — Front Line Agreement in Diagnosis and Treatment for Musculoskeletal Dysfunctions · NA · completed
- NCT02802410 — Cross Sectional Study to Evaluate Effects of Kinesiotaping on Muscle Activity During Climbing Stairs and Sport Activity · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04185896 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bern University of Applied Sciences
- Last refreshed: 4 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04185896.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing